{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T10:21:19Z","timestamp":1767176479550,"version":"build-2238731810"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1006775","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000}}],"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T00:00:00Z","timestamp":1551830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"German Federal Ministry of Research and Education, \u201cHaematoOPT\u201d project","award":["Grant number 031A424"],"award-info":[{"award-number":["Grant number 031A424"]}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1006775","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T15:38:12Z","timestamp":1551886692000},"page":"e1006775","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Modeling individual time courses of thrombopoiesis during multi-cyclic chemotherapy"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8356-2724","authenticated-orcid":true,"given":"Yuri","family":"Kheifetz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,3,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/annonc\/mdg249","article-title":"Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)","volume":"14","author":"A Wunderlich","year":"2003","journal-title":"Ann Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1056\/NEJMoa022473","article-title":"Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease","volume":"348","author":"V Diehl","year":"2003","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/annonc\/mdm541","article-title":"Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma","volume":"19","author":"M Ziepert","year":"2008","journal-title":"Ann Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jtbi.2009.12.032","article-title":"A biomathematical model of human thrombopoiesis under chemotherapy","volume":"264","author":"M Scholz","year":"2010","journal-title":"J Theor Biol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1182\/blood-2003-06-2095","article-title":"Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL","volume":"104","author":"M Pfreundschuh","year":"2004","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1182\/blood-2003-06-2094","article-title":"Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL","volume":"104","author":"M Pfreundschuh","year":"2004","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood.V86.10.3725.bloodjournal86103725","article-title":"Unilineage megakaryocytic proliferation and differentiation of purified hematopoietic progenitors in serum-free liquid culture","volume":"86","author":"R Guerriero","year":"1995","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1158\/0008-5472.CAN-06-4303","article-title":"Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor","volume":"67","author":"A Zeuner","year":"2007","journal-title":"Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2141.1975.tb00855.x","article-title":"Heterogeneity of rabbit platelets. V. Preferential splenic sequestration of megathrombocytes","volume":"31","author":"ML Freedman","year":"1975","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-82156-1","article-title":"Regulationsmodelle und ihre Anwendung auf die Blutbildung","author":"H-E Wichmann","year":"1984"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1182\/blood.V89.8.2782","article-title":"Human platelets as a model for the binding and degradation of thrombopoietin","volume":"89","author":"PJ Fielder","year":"1997","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0609.1974.tb00174.x","article-title":"Cyclic thrombocytopenia. Case report and review of literature","volume":"12","author":"T Cohen","year":"1974","journal-title":"Scand J Haematol"},{"issue":"Suppl 1","key":"ref13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/stem.5530140711","article-title":"The physiology of platelet production","volume":"14","author":"DJ Kuter","year":"1996","journal-title":"Stem Cells"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00285-004-0295-1","article-title":"Modelling human granulopoiesis under poly-chemotherapy with G-CSF support","volume":"50","author":"M Scholz","year":"2005","journal-title":"J Math Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1634\/stemcells.2007-0025","article-title":"Lineage specification of hematopoietic stem cells: mathematical modeling and biological implications","volume":"25","author":"I Glauche","year":"2007","journal-title":"Stem Cells"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0301-472X(02)00832-9","article-title":"A novel dynamic model of hematopoietic stem cell organization based on the concept of within-tissue plasticity","volume":"30","author":"I Roeder","year":"2002","journal-title":"Exp Hematol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nm0296-190","article-title":"Evidence that hematopoiesis may be a stochastic process in vivo","volume":"2","author":"JL Abkowitz","year":"1996","journal-title":"Nat Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nm.3707","article-title":"Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion","volume":"20","author":"I Bruns","year":"2014","journal-title":"Nat Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbrc.2014.10.095","article-title":"Megakaryocytes are essential for HSC quiescence through the production of thrombopoietin","volume":"454","author":"A Nakamura-Ishizu","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S8756-3282(03)00157-1","article-title":"Mathematical model predicts a critical role for osteoclast autocrine regulation in the control of bone remodeling","volume":"33","author":"SV Komarova","year":"2003","journal-title":"Bone"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13287-015-0164-4","article-title":"Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatment","volume":"6","author":"S Li","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.4161\/cc.9.13.12078","article-title":"Polyploid megakaryocytes can complete cytokinesis","volume":"9","author":"Y Leysi-Derilou","year":"2010","journal-title":"Cell Cycle"},{"key":"ref23","unstructured":"Leysi-Derilou Y. Monitoring and mathematical modeling of in vitro human megakaryocyte expansion and maturation dynamics. PhD thesis. Department of Chemical Engineering, Laval University, Qu\u00e9bec, QC Canada; 2011."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.diff.2011.12.003","article-title":"Single-cell level analysis of megakaryocyte growth and development","volume":"83","author":"Y Leysi-Derilou","year":"2012","journal-title":"Differentiation"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1006\/jtbi.2000.2149","article-title":"Regulation of platelet production: the normal response to perturbation and cyclical platelet disease","volume":"206","author":"M Santillan","year":"2000","journal-title":"J Theor Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood.V66.5.1105.1105","article-title":"Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement","volume":"66","author":"SR Hanson","year":"1985","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1038\/ncomms9983","article-title":"Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche","volume":"6","author":"MA Lawson","year":"2015","journal-title":"Nat Commun"},{"key":"ref28","article-title":"A molecular approach","author":"GM Cooper","year":"2000"},{"key":"ref29","first-page":"72","article-title":"Why do cells cycle with a 24 hour period","volume":"17","author":"S Bernard","year":"2006","journal-title":"Genome Inform"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1182\/blood.V95.8.2514","article-title":"Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers","volume":"95","author":"LA Harker","year":"2000","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1083\/jcb.147.6.1299","article-title":"Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes","volume":"147","author":"JR Italiano JE","year":"1999","journal-title":"J Cell Biol"},{"key":"ref32","article-title":"Stem cell regulation in Hemopoiesis","author":"HE Wichmann","year":"1985"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1742-4682-9-32","article-title":"Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans","volume":"9","author":"M Scholz","year":"2012","journal-title":"Theor Biol Med Model"},{"key":"ref34","first-page":"23","article-title":"Mechanisms of platelet production","volume":"15","author":"PE Stenberg","year":"1989","journal-title":"Blood Cells"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1182\/blood.V99.7.2599","article-title":"Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor","volume":"99","author":"RL Basser","year":"2002","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood.V98.12.3241","article-title":"Thrombocytopenia caused by the development of antibodies to thrombopoietin","volume":"98","author":"J Li","year":"2001","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.2830170114","article-title":"Kinetics and distribution of platelets in man","volume":"17","author":"MF Tsan","year":"1984","journal-title":"Am J Hematol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1537-2995.1998.38798346631.x","article-title":"Mathematical modeling of platelet survival with implications for optimal transfusion practice in the chronically platelet transfusion-dependent patient","volume":"38","author":"JK Hersh","year":"1998","journal-title":"Transfusion"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1365-2141.1999.01459.x","article-title":"Endogenous thrombopoietin serum levels during multicycle chemotherapy","volume":"105","author":"C Engel","year":"1999","journal-title":"Br J Haematol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1137\/S003614459933425X","article-title":"Solving Index-1 DAEs in MATLAB and Simulink","volume":"41","author":"LF Shampine","year":"1999","journal-title":"SIAM Rev"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1137\/S1064827594276424","article-title":"The MATLAB ODE Suite","volume":"18","author":"LF Shampine","year":"1997","journal-title":"SIAM J. Sci. Comput."},{"key":"ref42","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1200\/JCO.2002.02.140","article-title":"Model of chemotherapy-induced myelosuppression with parameter consistency across drugs","volume":"20","author":"LE Friberg","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1023\/A:1023573429626","article-title":"Mechanistic models for myelosuppression","volume":"21","author":"LE Friberg","year":"2003","journal-title":"Invest New Drugs"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1600-0609.1986.tb02283.x","article-title":"Oscillating platelet counts in healthy individuals: experimental investigation and quantitative evaluation of thrombocytopoietic feedback control","volume":"36","author":"GK von Schulthess","year":"1986","journal-title":"Scand J Haematol"},{"key":"ref45","first-page":"551","article-title":"A mathematical model of thrombopoiesis in rats","volume":"12","author":"HE Wichmann","year":"1979","journal-title":"Cell Tissue Kinet"},{"key":"ref46","article-title":"Dissertation","author":"C Kliem","year":"2001"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/00912700222011553","article-title":"Pharmacodynamic modeling of thrombopoietin, platelet, and megakaryocyte dynamics in patients with acute myeloid leukemia undergoing dose intensive chemotherapy","volume":"42","author":"SH Bernstein","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1365-2141.2003.04696.x","article-title":"New TPO treatment schedules of increased safety and efficacy: pre-clinical validation of a thrombopoiesis simulation model","volume":"123","author":"K Skomorovski","year":"2003","journal-title":"Br J Haematol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10637-005-6730-3","article-title":"Semi-physiological model describing the hematological toxicity of the anti-cancer agent indisulam","volume":"23","author":"C van Kesteren","year":"2005","journal-title":"Invest New Drugs"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1158\/1078-0432.CCR-07-0064","article-title":"Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group","volume":"13","author":"M Joerger","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cmpb.2008.10.011","article-title":"A tool for neutrophil guided dose adaptation in chemotherapy","volume":"93","author":"JE Wallin","year":"2009","journal-title":"Comput Methods Programs Biomed"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1742-7843.2009.00520.x","article-title":"Model-based neutrophil-guided dose adaptation in chemotherapy: evaluation of predicted outcome with different types and amounts of information","volume":"106","author":"JE Wallin","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.csda.2004.07.002","article-title":"Maximum likelihood estimation in nonlinear mixed effects models","volume":"49","author":"E Kuhn","year":"2005","journal-title":"Computational Statistics & Data Analysis"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12918-014-0138-7","article-title":"Modelling chemotherapy effects on granulopoiesis","volume":"8","author":"S Schirm","year":"2014","journal-title":"BMC Syst Biol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/bmt.2008.310","article-title":"G-CSF-induced thrombocytopenia in a healthy donor","volume":"43","author":"O Minelli","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1182\/blood.V97.8.2278","article-title":"Cyclophosphamide\/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle","volume":"97","author":"DE Wright","year":"2001","journal-title":"Blood"},{"key":"ref57","article-title":"Pharmacokinetics of Selected Anticancer Drugs in Elderly Cancer Patients: Focus on Breast Cancer","volume":"8","author":"M-RBS Crombag","year":"2016","journal-title":"Cancers (Basel)"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/bjc.2016.439","article-title":"Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients","volume":"116","author":"C Faivre","year":"2017","journal-title":"Br J Cancer"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1007110","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000}},{"DOI":"10.1371\/journal.pcbi.1006775","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1006775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T08:43:52Z","timestamp":1721033032000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1006775"}},"subtitle":[],"editor":[{"given":"Greg","family":"Tucker-Kellogg","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,6]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1006775","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,6]]}}}